The Nikkei average started 44.89 yen higher. Daikin Industries, Ltd. unsponsored ADR rebounded as it plans to increase production capacity in India.
![The Nikkei average started 44.89 yen higher. Daikin Industries, Ltd. unsponsored ADR rebounded as it plans to increase production capacity in India.](https://sgsnsimg.moomoo.com/sns_client_feed/181569713/20240903/46d4735371de22d6e4aa3b80dbc21730.png/big?area=105&is_public=true)
Good morning, moomoo users!
This is an overview of the opening this morning. Thank you.![]()
Market overview
In today's Tokyo stock market, the Nikkei average stock price started at 38,745.76 yen, up 44.89 yen from the previous trading day, and the Tokyo Stock Price Index (TOPIX) started at 2,717.45, up 1.46 points.
In today's Tokyo stock market, the Nikkei average stock price started at 38,745.76 yen, up 44.89 yen from the previous trading day, and the Tokyo Stock Price Index (TOPIX) started at 2,717.45, up 1.46 points.
![The Nikkei average started 44.89 yen higher. Daikin Industries, Ltd. unsponsored ADR rebounded as it plans to increase production capacity in India.](https://sgsnsimg.moomoo.com/sns_client_feed/181569713/20240903/751ca7e35d749338c9a96cddc2100a85.jpg/big?area=105&is_public=true)
Top news
Daikin Industries - rebounding, aiming to increase production capacity in India, where demand is expanding due to record heat waves.
$Daikin Industries (6367.JP)$Vroom is rebounding. Bloomberg reported on the 3rd that the company is moving to strengthen its production capacity in India, where air conditioner sales are further growing due to record heat waves. It is said that they plan to purchase land near their main factory in the southern region and build a new building.
Daikin Industries - rebounding, aiming to increase production capacity in India, where demand is expanding due to record heat waves.
$Daikin Industries (6367.JP)$Vroom is rebounding. Bloomberg reported on the 3rd that the company is moving to strengthen its production capacity in India, where air conditioner sales are further growing due to record heat waves. It is said that they plan to purchase land near their main factory in the southern region and build a new building.
Advantest is performing well, upgraded to "buy" by Goldman Sachs.
Goldman Sachs $Advantest (6857.JP)$Upgraded its investment rating from 'hold' to 'buy'. The target stock price is 8100 yen.
Goldman Sachs $Advantest (6857.JP)$Upgraded its investment rating from 'hold' to 'buy'. The target stock price is 8100 yen.
Ito En is cheaper, with a 29% decrease in operating profit for the 5-7 month period due to increased sales and administrative expenses such as advertising and publicity.
$ITO EN (2593.JP)$ announced its consolidated financial results for the 5-7 month period after the end of trading on the 2nd. Sales increased by 3.2% to 125.39 billion yen compared to the same period last year, while operating profit decreased by 28.7% to 7.128 billion yen.
$ITO EN (2593.JP)$ announced its consolidated financial results for the 5-7 month period after the end of trading on the 2nd. Sales increased by 3.2% to 125.39 billion yen compared to the same period last year, while operating profit decreased by 28.7% to 7.128 billion yen.
HOYA is cheaper - Goldman Sachs downgraded it from 'hold' to 'neutral'.
$Hoya (7741.JP)$ Downgraded its investment rating from 'buy' to 'neutral'. The target stock price is 20,000 yen.
$Hoya (7741.JP)$ Downgraded its investment rating from 'buy' to 'neutral'. The target stock price is 20,000 yen.
Takeda Pharmaceutical is slightly up - Signed a licensing agreement for new cancer drugs with the progress of U.S. biotech and new cancer drugs.
According to the Nikkei report, Takeda has signed a licensing agreement for a new cancer drug with the U.S. biotech startup Kumquat Biosciences. Takeda may pay approximately 1.2 billion dollars (about 170 billion yen) based on the progress of development and other factors to Kumquat.
According to the Nikkei report, Takeda has signed a licensing agreement for a new cancer drug with the U.S. biotech startup Kumquat Biosciences. Takeda may pay approximately 1.2 billion dollars (about 170 billion yen) based on the progress of development and other factors to Kumquat.
Osaka Titanium Co. soars, announces increase in sponge titanium production capacity
$OSAKA Titanium technologies (5726.JP)$ , announces an increase in sponge titanium production. With the recovery of aircraft demand and a turning point in growth, the production capacity of the Amagasaki factory is being enhanced.
$OSAKA Titanium technologies (5726.JP)$ , announces an increase in sponge titanium production. With the recovery of aircraft demand and a turning point in growth, the production capacity of the Amagasaki factory is being enhanced.
Workman - rebounds after 5 days, existing store revenue in August increased by 8.0%, with a total store increase of 11.5%
$Workman (7564.JP)$ rebounded after 5 days. The company announced the preliminary report for the month of August on the 2nd. The existing store revenue was 8.0% higher than the same month last year. Total store revenue increased by 11.5%.
$Workman (7564.JP)$ rebounded after 5 days. The company announced the preliminary report for the month of August on the 2nd. The existing store revenue was 8.0% higher than the same month last year. Total store revenue increased by 11.5%.
Source: The Nikkei, Bloomberg, Trader's Web
-moomoo News Kathy
-moomoo News Kathy
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment